dc.creatorSCHIPER, LUIS
dc.creatorFAINTUCH, BLUMA L.
dc.creatorBADARO, ROBERTO J. da S.
dc.creatorOLIVEIRA, ERICA A. de
dc.creatorCHAVEZ, VICTOR E.A.
dc.creatorCHINEN, ELISANGELA
dc.creatorFAINTUCH, JOEL
dc.date2016
dc.date2017-01-05T16:58:29Z
dc.date2017-01-05T16:58:29Z
dc.date.accessioned2023-09-28T13:32:03Z
dc.date.available2023-09-28T13:32:03Z
dc.identifier1807-5932
dc.identifierhttp://repositorio.ipen.br/handle/123456789/26969
dc.identifier10
dc.identifier71
dc.identifier10.6061/clinics/2016(10)11
dc.identifier42.903
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8997257
dc.descriptionOBJECTIVES: Conventional imaging methods are excellent for the morphological characterization of the consequences of osteonecrosis; however, only specialized techniques have been considered useful for obtaining functional information. To explore the affinity of radiotracers for severely devascularized bone, a new mouse model of isolated femur implanted in a subcutaneous abdominal pocket was devised. To maintain animal mobility and longevity, the femur was harvested from syngeneic donors. Two technetium-99m-labeled tracers targeting angiogenesis and bone matrix were selected. METHODS: Medronic acid and a homodimer peptide conjugated with RGDfK were radiolabeled with technetium-99m, and biodistribution was evaluated in Swiss mice. The grafted and control femurs were evaluated after 15, 30 and 60 days, including computed tomography (CT) and histological analysis. RESULTS: Radiolabeling achieved high (>95%) radiochemical purity. The biodistribution confirmed good blood clearance 1 hour after administration. For Tc-99m-hydrazinonicotinic acid (HYNIC)-E-[c(RGDfK)(2), remarkable renal excretion was observed compared to Tc-99m-methylene diphosphonate (MDP), but the latter, as expected, revealed higher bone uptake. The results obtained in the control femur were equal at all time points. In the implanted femur, Tc-99m-HYNIC-E-[c(RGDfK)(2) uptake was highest after 15 days, consistent with early angiogenesis. Regarding Tc-99m-MDP in the implant, similar uptake was documented at all time points, consistent with sustained bone viability; however, the uptake was lower than that detected in the control femur, as confirmed by histology. CONCLUSIONS: 1) Graft viability was successfully diagnosed using radiotracers in severely ischemic bone at all time points. 2) Analogously, indirect information about angiogenesis could be gathered using Tc-999m-HYNIC-E-[c(RGDfK)(2). 3) These techniques appear promising and warrant further studies to determine their potential clinical applications.
dc.format617-625
dc.relationClinics
dc.rightsopenAccess
dc.subjectskeleton
dc.subjectimplants
dc.subjectviability
dc.subjecttracer techniques
dc.subjectradioactive tracers
dc.subjectnecrosis
dc.subjectmice
dc.subjectanimals
dc.subjectangiogenesis
dc.subjectfemur
dc.subjecttechnetium isotopes
dc.subjecttechnetium 99
dc.subjectbiological models
dc.subjectimages
dc.titleFunctional investigation of bone implant viability using radiotracers in a new model of osteonecrosis
dc.typeArtigo de peri??dico
dc.coverageI


Este ítem pertenece a la siguiente institución